Richard Straube
Director Técnico/Científico/I+D en SOLIGENIX, INC. .
Fortuna: 228 $ al 30/04/2024
Cargos activos de Richard Straube
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SOLIGENIX, INC. | Director Técnico/Científico/I+D | 06/01/2014 | - |
Historial de carrera de Richard Straube
Antiguos cargos conocidos de Richard Straube.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Director Técnico/Científico/I+D | 01/01/2009 | 06/01/2014 |
Critical Biologics Corp.
 Critical Biologics Corp. Medical SpecialtiesHealth Technology Critical Biologics Corp. develops and commercializes diagnostics and therapeutics drugs. The firm focuses in the development of a theranostic platform to screen and treat both acute and chronic patients with low plasma gelsolin levels (hypogelsolinemia) at high risk of life-threatening complications. The company was founded by James W. Fordyce, Terence S. Russell, Shun Lee Po, and Thomas P. Stossel in 2006 and is headquartered in Cambridge, MA. | Director Técnico/Científico/I+D | 14/06/2007 | 01/01/2009 |
INO Therapeutics LLC
 INO Therapeutics LLC Pharmaceuticals: MajorHealth Technology INO Therapeutics LLC engages in the development of pharmaceutical drugs. The company is headquartered in Hampton, NJ. | Director Técnico/Científico/I+D | 01/01/1998 | 01/01/2007 |
| Ohmeda, Inc. | Corporate Officer/Principal | 01/01/1995 | 02/01/1997 |
| T Cell Sciences, Inc. | Director Técnico/Científico/I+D | 01/01/1993 | 01/01/1995 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Director Técnico/Científico/I+D | 01/01/1988 | 01/01/1993 |
Inomax LLC (Florida)
 Inomax LLC (Florida) Investment ManagersFinance Inomax LLC is an American venture capital company. | Corporate Officer/Principal | - | - |
| University of California San Diego | Corporate Officer/Principal | 01/01/1984 | - |
Formación de Richard Straube.
| The University of Chicago | Doctorate Degree |
| London School of Hygiene & Tropical Medicine | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 11 |
| Reino Unido | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 6 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 4 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| Empresas privadas | 7 |
|---|---|
Critical Biologics Corp.
Critical Biologics Corp. Medical SpecialtiesHealth Technology Critical Biologics Corp. develops and commercializes diagnostics and therapeutics drugs. The firm focuses in the development of a theranostic platform to screen and treat both acute and chronic patients with low plasma gelsolin levels (hypogelsolinemia) at high risk of life-threatening complications. The company was founded by James W. Fordyce, Terence S. Russell, Shun Lee Po, and Thomas P. Stossel in 2006 and is headquartered in Cambridge, MA. | Health Technology |
| T Cell Sciences, Inc. | Health Technology |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Inomax LLC (Florida)
Inomax LLC (Florida) Investment ManagersFinance Inomax LLC is an American venture capital company. | Finance |
INO Therapeutics LLC
INO Therapeutics LLC Pharmaceuticals: MajorHealth Technology INO Therapeutics LLC engages in the development of pharmaceutical drugs. The company is headquartered in Hampton, NJ. | Health Technology |
| Ohmeda, Inc. | |
Stealth BioTherapeutics Corp.
 Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company was founded on April 3, 2006 and is headquartered in Needham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Richard Straube
- Experiencia
